Inovio Pharmaceuticals Inc (INO)
10.20
-0.87
(-7.86%)
USD |
NASDAQ |
Apr 18, 16:00
10.22
+0.02
(+0.20%)
After-Hours: 20:00
Inovio Pharmaceuticals Debt to Equity Ratio: 0.1429 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.1429 |
| September 30, 2023 | 0.1193 |
| June 30, 2023 | 0.0986 |
| March 31, 2023 | 0.0823 |
| December 31, 2022 | 0.0747 |
| September 30, 2022 | 0.0611 |
| June 30, 2022 | 0.0555 |
| March 31, 2022 | 0.0456 |
| December 31, 2021 | 0.0374 |
| September 30, 2021 | 0.0319 |
| June 30, 2021 | 0.0286 |
| March 31, 2021 | 0.0242 |
| December 31, 2020 | 0.0405 |
| September 30, 2020 | 0.1658 |
| June 30, 2020 | 0.4272 |
| March 31, 2020 | 0.4153 |
| December 31, 2019 | 22.42 |
| September 30, 2019 | 2.080 |
| June 30, 2019 | 1.170 |
| March 31, 2019 | 0.7773 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0242
Minimum
Mar 2021
22.42
Maximum
Dec 2019
1.449
Average
0.0823
Median
Mar 2023
Debt to Equity Ratio Benchmarks
| Cerus Corp | 1.516 |
| Stereotaxis Inc | 0.00 |
| Viemed Healthcare Inc | 0.0621 |
| AIM ImmunoTech Inc | 0.00 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 170.95M |
| Total Liabilities (Quarterly) | 53.60M |
| Shareholders Equity (Quarterly) | 117.35M |
| Current Ratio | 3.597 |
| Net Debt Paydown Yield | -0.07% |